Greenyn Biotechnology Co (ROCO:6846) ROCE %: 14.68% (As of Dec. 2025)


ROCO:6846 Greenyn Biotechnology Co Ltd ROCO:6846
65 GF Score
Price NT$63.70
GF Value NT$66.84
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Greenyn Biotechnology Co ROCE %?

Greenyn Biotechnology Co ROCO:6846 65 ROCE % is 14.68% as of Dec. 2025. GuruFocus rates ROCO:6846 with a GF Score™ of 65/100 and a GF Value™ of NT$66.84 (Fairly Valued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Greenyn Biotechnology Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 14.68%.

Greenyn Biotechnology Co  (ROCO:6846) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Greenyn Biotechnology Co ROCE % Related Terms

Greenyn Biotechnology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Greenyn Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenyn Biotechnology Co ROCE % Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 27.81 29.27 22.87 21.04 14.08

Greenyn Biotechnology Co Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.90 18.79 6.99 9.79 14.68
ROCO:6846
65GF Score
Greenyn Biotechnology Co Ltd ROCO:6846
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenyn Biotechnology Co ROCE % Calculation

Greenyn Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=196.931/( ( (1108.668 - 203.599) + (2109.409 - 217.105) )/ 2 )
=196.931/( (905.069+1892.304)/ 2 )
=196.931/1398.6865
=14.08 %

Greenyn Biotechnology Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=273.64/( ( (2041.999 - 206.742) + (2109.409 - 217.105) )/ 2 )
=273.64/( ( 1835.257 + 1892.304 )/ 2 )
=273.64/1863.7805
=14.68 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.68% mean?
Greenyn Biotechnology Co (ROCO:6846) has a ROCE % of 14.68% as of Dec. 2025.
Is Greenyn Biotechnology Co's ROCE % too high?
Greenyn Biotechnology Co's current ROCE % is 14.68%. Overall, Greenyn Biotechnology Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Greenyn Biotechnology Co's ROCE % compare to VRTX and REGN?
Greenyn Biotechnology Co's ROCE % of 14.68% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Greenyn Biotechnology Co's current ROCE % is 14.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenyn Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Greenyn Biotechnology Co (ROCO:6846) is currently considered Fairly Valued. The stock's GF Value™ is NT$66.84, compared to a current price of NT$63.70 — trading 4.7% below its estimated fair value. The current ROCE % is 14.68%. Greenyn Biotechnology Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Greenyn Biotechnology Co (ROCO:6846), the current ROCE % is 14.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenyn Biotechnology Co (ROCO:6846) Overvalued in 2026?

Based on GuruFocus' analysis, Greenyn Biotechnology Co stock appears to be undervalued. The current stock price of NT$63.70 is trading 4.7% below its estimated GF Value™ of NT$66.84. GuruFocus considers Greenyn Biotechnology Co to be Fairly Valued.

Key valuation signals for ROCO:6846:

  • ROCE %: 14.68%
  • GF Value™: NT$66.84 vs. price of NT$63.70 (4.7% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Greenyn Biotechnology Co Business Description

Address No 43 Keya Road, 5th Floor, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
65GF Score

Get the complete analysis for ROCO:6846

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.70
Price
NT$66.84
GF Value